SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Sanofi (France) Release: Lyxumia® (lixisenatide) in Combination with Basal Insulin Plus Oral Anti-Diabetics Significantly Reduced HbA1c and Post-Prandial Glucose
Your Message